Search company, investor...
RIMSYS company logo

RIMSYS

rimsys.io

Founded Year

2017

Stage

Series A | Alive

Total Raised

$20.6M

Last Raised

$16M | 1 yr ago

Revenue

$0000 

About RIMSYS

RIMSYS Regulatory Management Software is a suite of cloud-based regulatory affairs software solutions for medical device manufacturers.

Headquarters Location

100 S. Commons Suite 102

Pittsburgh, Pennsylvania, 15212,

United States

Missing: RIMSYS's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: RIMSYS's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing RIMSYS

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

RIMSYS is included in 1 Expert Collection, including Digital Health.

D

Digital Health

13,118 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Latest RIMSYS News

Rimsys and QualiZeal Announce Strategic Partnership for Quality Engineering Transformation

May 31, 2022

QualiZeal to provide Test Advisory, Quality Engineering, Test Automation and Quality Governance & Management services to Rimsys Download QualiZeal and Rimsys Team (Photo: Business Wire) May 31, 2022 10:35 AM Eastern Daylight Time IRVING, Texas--( BUSINESS WIRE )--QualiZeal, a leading Digital Quality Engineering services company, announced strategic long-term partnership with Pittsburgh-based Rimsys, the leading and only holistic RIM software for MedTech. Rimsys has chosen QualiZeal to help enable their desire to build superior quality products and enhance customer experience. Through this engagement, QualiZeal will work with Rimsys to establish a world class Quality Engineering organization to help Rimsys deliver superior products with a faster time to market. Brady Ryba, CTO & Co-Founder, Rimsys – “RIM (Regulatory Information Management) software systems are becoming increasingly necessary as more and more countries adopt specific market entrance requirements and the global regulatory landscape becomes increasingly complex. This leaves MedTech regulatory professionals on the front lines, responsible for correctly deciphering entrance requirements and coordinating the assembly of complex submission documents. QualiZeal shares our quality vision & values and brings in delivery excellence, quality engineering expertise and willingness to walk extra mile for mutual success. I am sure that this partnership will enrich our customer experience and product quality.” Kote Bipilli, SVP – Client Success, QualiZeal, said, “We are delighted to be have been selected as the Quality Engineering partner to help Rimsys, the leading holistic RIM software provider, in their digital journey. Leveraging our Global delivery model, Quality Engineering offerings and Assets & Platforms we are committed to drive excellence in transforming their software testing methodology, test organization maturity and user experience of the products.” About Rimsys Rimsys is on a mission to bring regulatory order to the MedTech industry. The Rimsys Regulatory Information Management (RIM) platform digitizes and automates regulatory activities, freeing teams from inefficient administrative work, and helping them confidently establish and secure global regulatory compliance. Unlike complex, color-coded spreadsheets, or expensive external consultants, Rimsys seamlessly centralizes all regulatory information, automates submission processes, and monitors relevant expirations, standards, and global regulations. Traditional approaches to regulatory affairs can’t keep pace with the growing complexity of the global landscape, and overburdened teams face increasing compliance risks. Rimsys streamlines all regulatory activities including registrations, essential principles, UDI, standards management, and regulatory intelligence in a single, integrated platform. Leading global MedTech companies including Johnson & Johnson, Siemens Healthiness, and Omron rely on Rimsys to get new products to market more quickly, and reduce revenue risk of non-compliance, product recalls, and unexpected expirations. For more information, visit www.rimsys.io . About QualiZeal QualiZeal is a trusted partner for end-to-end, Quality Engineering solutions and services for the digital world. We help our clients tackle quality engineering challenges through our innovative solutions that will help them to harness technological changes and gain a competitive advantage. For more information, visit www.qualizeal.com . Contacts

RIMSYS Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

RIMSYS Rank

RIMSYS Frequently Asked Questions (FAQ)

  • When was RIMSYS founded?

    RIMSYS was founded in 2017.

  • Where is RIMSYS's headquarters?

    RIMSYS's headquarters is located at 100 S. Commons, Pittsburgh.

  • What is RIMSYS's latest funding round?

    RIMSYS's latest funding round is Series A.

  • How much did RIMSYS raise?

    RIMSYS raised a total of $20.6M.

  • Who are the investors of RIMSYS?

    Investors of RIMSYS include Allos Ventures, Innovation Works, Bessemer Venture Partners and Private Opportunities.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.